Monthly Archives: April 2021

Advance the development of safe and effective regenerative medicine products

[ad_1] Picture By: Peter Marks, MD, Ph.D., Director, Center for Biologics Assessment and Research The United States Food and Drug Administration plays a vital role in facilitating the development and availability of innovative medical products. Products such as cell-derived therapies, including stem cell products, offer the potential to treat or …

Read More »

Precision Medicine Company adyn Raises $ 2.5 Million Seed Funding for Personalized Birth Control

[ad_1] Gives women personalized contraceptive recommendations to minimize side effects of medications, including blood clots and depression SEATTLE – (COMMERCIAL THREAD) – adyn, a precision medicine company, today announced it has closed a $ 2.5 million funding round. The round was co-led by Lux Capital and M13 with participation from …

Read More »